{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:57:49Z","timestamp":1762459069841,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.4158\/ep.11.2.108","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:32:59Z","timestamp":1365197579000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Persistent Tumor-Induced Osteomalacia Confirmed by Elevated Postoperative Levels of Serum Fibroblast Growth Factor-23 and 5-Year Follow-up of Bone Density Changes"],"prefix":"10.1016","volume":"11","author":[{"given":"Mark B.","family":"Zimering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice A.","family":"Caldarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.11.2.108_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for the derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"10.4158\/EP.11.2.108_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol."},{"key":"10.4158\/EP.11.2.108_bb0015","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast-growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.11.2.108_bb0020","first-page":"33","article-title":"Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"McCance","year":"1947","journal-title":"QJ Med."},{"key":"10.4158\/EP.11.2.108_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90112-8","article-title":"Oncogenous osteomalacia: review of the world literature of 42 cases and report of two new cases","volume":"77","author":"Ryan","year":"1984","journal-title":"Am J Med."},{"key":"10.4158\/EP.11.2.108_bb0030","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"319","article-title":"Tumor-induced rickets and osteomalacia","author":"Drezner","year":"1996"},{"key":"10.4158\/EP.11.2.108_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","year":"2000","journal-title":"Nat Genet."},{"key":"10.4158\/EP.11.2.108_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.2.108_bb0045","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.11.2.108_bb0050","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"De Beur","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.11.2.108_bb0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9343(87)90711-X","article-title":"Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: effect of successful tumor resection on mineral homeostasis","volume":"83","author":"Reid","year":"1987","journal-title":"Am J Med."},{"key":"10.4158\/EP.11.2.108_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.11.2.108_bb0065","first-page":"633","article-title":"Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor","volume":"56","author":"Izbicka","year":"1996","journal-title":"Cancer Res."},{"key":"10.4158\/EP.11.2.108_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1359\/jbmr.1999.14.5.776","article-title":"Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells","volume":"14","author":"Hurley","year":"1999","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.11.2.108_bb0075","doi-asserted-by":"crossref","first-page":"21258","DOI":"10.1074\/jbc.M302113200","article-title":"Impaired osteoclast formation in bone marrow cultures of FGF2 null mice in response to parathyroid hormone","volume":"278","author":"Okada","year":"2003","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.11.2.108_bb0080","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [erratum in N Engl J Med. 2000;342:144]","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med."},{"issue":"Suppl 2","key":"10.4158\/EP.11.2.108_bb0085","first-page":"N154","article-title":"The basis for the post-parathyroidectomy increase in bone mass","volume":"17","author":"Heaney","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.11.2.108_bb0090","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1210\/endo.140.12.7195","article-title":"Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats","volume":"140","author":"Liang","year":"1999","journal-title":"Endocrinology"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20399018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20399018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/NE0TD7VP8KK34J8K.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:42Z","timestamp":1761515142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20399018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1530891X20399018"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.2.108","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent Tumor-Induced Osteomalacia Confirmed by Elevated Postoperative Levels of Serum Fibroblast Growth Factor-23 and 5-Year Follow-up of Bone Density Changes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.2.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}